← Return to Preliminary Guidelines for Adult Bronchiectasis
DiscussionPreliminary Guidelines for Adult Bronchiectasis
MAC & Bronchiectasis | Last Active: Oct 31 11:34am | Replies (21)Comment receiving replies
Replies to "@kathyjjb You’re welcome. I think it is a risk / benefit analysis. If you take the..."
@jnmy I'm not really surprised. I understand the risk/benefit. After being diagnosed with macrolide resistant M. Abscessus and told the cure rate is only 45% (25% with cavity disease), the risk to benefit quickly becomes meaningless. Not to mention the drugs needed from day 1-are much more toxic than azithromycin (though there are exceptions). I would like to see a study of BE participants without an NTM and taking the prophylactic macrolides and following the participants for 5 years. I think the solution, like "beclear" suggested would be monthly sputum cultures (if possible). Particularly for MABC that has a fast growth rate-so culture turn around can be very fast-depending on the lab. I would want to send to NJH lab and definitely discuss with my ID doctor. Thank you for bringing it up, I can see the benefit-particularly since I will not be using Brinsupri anytime soon.
Connect

@kathyjjb
Here is the journal article I mentioned above.
The data is based on the US registry of Bronchiectasis patients and I think some researchers believe that people in the registry may have more severe symptoms.
Could that impact the results / conclusions?